Randomised Double-Blind Comparison of Placebo and Active Drugs for Effects on Risks Associated with Blood Pressure Variability in the Systolic Hypertension in Europe Trial

• Azusa Hara,

  Affiliation Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium

  ⨯
• Lutgarde Thijs,

  Affiliation Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium

  ⨯
• Kei Asayama,

  Affiliations Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium, Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan

  ⨯
• Lotte Jacobs,

  Affiliation Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium

  ⨯
• Ji-Guang Wang,

  Affiliation Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯
• Jan A. Staessen

  * E-mail: jan.staessen@med.kuleuven.be

  Affiliations Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium, Department of Epidemiology, Maastricht University, Maastricht, the Netherlands

  ⨯